30 Participants Needed

Sleep and Exercise for Alzheimer's Disease

(CASE Trial)

Recruiting at 1 trial location
JM
AA
DC
Overseen ByDebbie Chung, PhD
Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: NYU Langone Health
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)
Approved in 1 JurisdictionThis treatment is already approved in other countries

What You Need to Know Before You Apply

What is the purpose of this trial?

This trial aims to explore how sleep and exercise influence the risk of dementia over time. It involves different groups: some will focus only on sleep, others only on exercise, and some on both. Participants will use devices like the DREEM 2 Headband (a sleep tracking device) and a Fitbit (a wristwatch activity tracker) to monitor their sleep and activity. Individuals who have experienced issues with memory, concentration, or processing information and can perform mild exercise might be a good fit for this trial. As an unphased study, this trial offers a unique opportunity to contribute to understanding lifestyle impacts on dementia risk.

Will I have to stop taking my current medications?

The trial information does not specify whether you need to stop taking your current medications.

What prior data suggests that the DREEM 2 Headband and Exercise Routine are safe?

Research has shown that the Dreem 2 headband is generally well-tolerated by older adults. Studies with participants around 70 years old found no major side effects from using the headband, suggesting it is safe for tracking sleep patterns.

Evidence indicates that regular physical activity is both safe and beneficial. The World Health Organization advises adults to engage in 150 to 300 minutes of moderate exercise each week. This level of activity is considered safe and can help reduce the risk of dementia.

Overall, both the Dreem 2 headband and the exercise routine appear safe based on past research. However, it is important to consult a healthcare provider before starting any new program.12345

Why are researchers excited about this trial?

Researchers are excited about this trial because it explores how combining exercise and improved sleep can impact Alzheimer's disease. While current treatments for Alzheimer's mainly involve medications like donepezil or memantine that target brain chemicals, this trial focuses on lifestyle changes. The unique aspect here is the use of the DREEM 2 headband to enhance sleep quality, paired with a structured exercise routine. By studying these non-drug interventions, researchers hope to find sustainable, side-effect-free ways to improve cognitive function and quality of life for those with Alzheimer's.

What evidence suggests that this trial's treatments could be effective for reducing dementia risk?

Research has shown that regular exercise can help reduce the risk of Alzheimer's disease. Studies have found that older adults who stay active are more likely to maintain sharp mental abilities. One study suggested that exercise can slow memory and thinking problems in people with Alzheimer's. Additionally, exercise might lower the chance of developing dementia by up to 20%. In this trial, participants in the Exercise Only Group will follow a workout routine twice a week for 12 weeks. Meanwhile, the DREEM 2 headband, used in the Sleep Only Group, tracks sleep, though current data does not clearly show its impact on reducing dementia risk. Participants in the Exercise and Sleep Group will combine both interventions, as good sleep is generally considered beneficial for brain health.12678

Who Is on the Research Team?

AA

Azizi A Seixas, PhD

Principal Investigator

University of Miami

Are You a Good Fit for This Trial?

This trial is for individuals experiencing memory, concentration, or information processing issues who can do mild exercise and wear a DREEM 2 Headband and Fitbit watch. They must be able to handle a digital device and perform the Everlywell biomarker test. Participants should speak English and consent willingly.

Inclusion Criteria

I am mentally capable and agree to participate.
I can do the Everlywell biomarker test.
I can use a smartphone, tablet, or computer.
See 4 more

Exclusion Criteria

You are not allowed to do light exercise or have difficulty doing so.
Unable or unwilling to consent for any reason.
Unable to wear wrist watch or headband devices, or unable to supply pinprick blood sample for any reason
See 2 more

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Treatment

Participants engage in sleep and/or exercise interventions for 12 weeks

12 weeks
Weekly check-ins (virtual or in-person)

Follow-up

Participants are monitored for safety and effectiveness after treatment

4 weeks

What Are the Treatments Tested in This Trial?

Interventions

  • DREEM 2 Headband
  • Exercise Routine
  • Fitbit
Trial Overview The study examines how sleep quality and an exercise routine might influence dementia risk over time using tools like the DREEM 2 Headband to monitor sleep patterns and a Fitbit watch to track activity levels.
How Is the Trial Designed?
3Treatment groups
Experimental Treatment
Active Control
Group I: Sleep Only GroupExperimental Treatment1 Intervention
Group II: Exercise Only GroupActive Control1 Intervention
Group III: Exercise and Sleep GroupActive Control2 Interventions

Find a Clinic Near You

Who Is Running the Clinical Trial?

NYU Langone Health

Lead Sponsor

Trials
1,431
Recruited
838,000+

University of Miami

Lead Sponsor

Trials
976
Recruited
423,000+

Dreem

Industry Sponsor

Trials
7
Recruited
280+

Shipley Foundation

Collaborator

Trials
1
Recruited
30+

Published Research Related to This Trial

A review of 14 studies on exercise and Alzheimer's disease found that exercise can significantly improve daily functioning and performance in patients, enhancing their ability to carry out daily activities.
Exercise also positively impacts neuropsychiatric symptoms and various cognitive functions, including sustained attention and visual memory, suggesting it may be a valuable intervention for managing Alzheimer's disease.
What are the Benefits of Exercise for Alzheimer's Disease? A Systematic Review of the Past 10 Years.Hernández, SS., Sandreschi, PF., da Silva, FC., et al.[2018]
A multimodal exercise program over 6 months significantly improved sleep disturbances and performance in instrumental activities of daily living for patients with Alzheimer's and Parkinson's diseases, as shown in a study of 77 participants.
In contrast, control groups showed either maintenance or worsening of these conditions, highlighting the potential benefits of regular physical exercise for cognitive health in these populations.
Effect of a multimodal exercise program on sleep disturbances and instrumental activities of daily living performance on Parkinson's and Alzheimer's disease patients.Nascimento, CM., Ayan, C., Cancela, JM., et al.[2015]
A home-based exercise program for patients with Alzheimer's Disease (AD) showed good adherence and a trend towards improved functional performance, particularly in hand function and lower extremity strength, after 6 and 12 weeks.
Despite the positive trends in functional performance, there were also indications of worse depression and lower quality of life ratings among participants, suggesting the need for further research to optimize the intervention.
Evaluation of a home-based exercise program in the treatment of Alzheimer's disease: the Maximizing Independence in Dementia (MIND) study.Steinberg, M., Leoutsakos, JM., Podewils, LJ., et al.[2022]

Citations

Evaluation of Dreem headband for sleep staging and EEG ...The DHB 2 uses five dry electrodes: three frontal (Fp2 [ground], F7 and F8) and two occipital (O1 and O2) electrodes to collect the EEG data.
2.pubmed.ncbi.nlm.nih.govpubmed.ncbi.nlm.nih.gov/40319389/
Evaluation of Dreem headband for sleep staging and EEG ...We assessed the Dreem headband (DHB) and its automated sleep staging algorithm in 62 older adults [age (mean±SD) 70.5±6.7 years; 12 Alzheimer's].
Performance of the Dreem 2 EEG headband, relative to ...Core outcomes. Summary statistics showed Dreem Headband overestimated several sleep metrics, including total sleep, efficiency, deep sleep, and rapid eye ...
Evaluation of Dreem headband for sleep staging and EEG ...We assessed the Dreem headband (DHB) and its automated sleep staging algorithm in 62 older adults [age (mean ± SD) 70.5 ± 6.7 years; 12 Alzheimer's disease].
Remote evaluation of sleep to enhance understanding of ...Dreem 2 records, stores, and analyses EEG data collected via 5 dry sensors (two frontal sensors at F7 and F8, one ground sensor at Fp2, and two ...
6.pubmed.ncbi.nlm.nih.govpubmed.ncbi.nlm.nih.gov/38151377/
Performance of the Dreem 2 EEG headband, relative to ...The Dreem Headband performs similarly in Parkinson's disease as it did in non-Parkinson's disease samples and shows promise for improving access to sleep ...
Acoustic stimulation as a promising technique to enhance ...(A) We used the DREEM 2 headband device (DH) to record sleep data and to stimulate the slow-wave activity by closed-loop acoustic stimulation. The DH was worn ...
Evaluation of Dreem headband for sleep staging and EEG ...Methods: We assessed the Dreem headband (DHB), and its automated sleep staging algorithm in 62 older adults [Age (mean±SD) 70.5±6.7 years; 12 ...
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of Service·Privacy Policy·Cookies·Security